Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation BCG: correlation with cell-mediated immunity.
D000368:Aged; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D001706:Biopsy; D002250:Carbon Radioisotopes; D005260:Female; D006650:Histocompatibility Testing; D006801:Humans; D007104:Immune Adherence Reaction; D007111:Immunity, Cellular; D007167:Immunotherapy; D007267:Injections; D037102:Lectins / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D008263:Macrophage Migration-Inhibitory Factors; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D008854:Microscopy, Electron; D008875:Middle Aged; D009362:Neoplasm Metastasis; D012882:Skin Tests
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002250:Carbon Radioisotopes; D037102:Lectins; D008263:Macrophage Migration-Inhibitory Factors